Use of glycosylated haemoglobin as diagnostic tool in Greenland: Prevalence of diagnosed diabetes mellitus

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Damsgaard, Line ^a   Pedersen, Michael Lynge ^a,b  

^a Queen Ingrid Health Care Centre   (Greenland)

^b UNIVERSITY OF GREENLAND   (Greenland)

Author keywords

Diabetes mellitus; Glycohemoglobin; Greenlanders; Haemoblobin A1C; Inuit

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; GREENLAND; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 84885065635     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-59     Document Type: Article

References (30)

1. Bjerregaard P, Young TK, The circumpolar Inuit-health of a population in transition Copenhagen: Munksgaard 1998 23986904
2. Indigenous health in the Arctic: an overview of the circumpolar Inuit population. Bjerregaard P, Young TK, Dewailly E, Ebbesson SO, Scand J Public Health 2004 32 390 395 10.1080/14034940410028398 15513673
3. Changing living conditions, life style and health. Curtis T, Kvernmo S, Bjerregaard P, Int J Circumpolar Health 2005 64 442 450 16440606
4. Inuit health in Greenland: a population survey of life style and disease in Greenland and among Inuit living in Denmark. Bjerregaard P, Curtis T, Borch-Johnsen K, Mulvad G, Becker U, Andersen S, Backer V, Int J Circumpolar Health 2003 62 3 79 14527126
5. Bjerregaard P, Aidt EC, Life conditions, lifestyle and health-population surveys in Greenland 2005-2009. [Danish and Greenlandic] Copenhagen: University of Southern Denmark 2010 1 30 24100671
6. Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Jørgensen ME, Bjerregaard P, Borch-Johnsen K, Backer V, Becker U, Jørgensen T, et al. Diabetes Care 2002 25 1766 1771 10.2337/diacare.25.10.1766 12351475 (Pubitemid 41071084)
7. High prevalence of markers of coronary heart disease among Greenland Inuit. Jørgensen ME, Bjerregaard P, Kjaergaard JJ, Borch-Johnsen K, Atherosclerosis 2008 196 772 778 10.1016/j.atherosclerosis.2007.01.008 17306273
8. Cardiovascular disease and risk factors in three Alaskan Eskimo populations: the Alaska-Siberia project. Ebbesson SO, Adler AI, Risica PM, Ebbesson LO, Yeh JL, Go OT, Doolittle W, Ehlert G, Swenson M, Robbins DC, Int J Circumpolar Health 2005 64 365 386 16277121
9. Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. Howard BV, Comuzzie A, Devereux RB, Ebbesson SO, Fabsitz RR, Howard WJ, Laston S, MacCluer JW, Silverman A, Umans JG, Wang H, Weissman NJ, Wenger CR, Nutr Metab Cardiovasc Dis 2010 20 350 358 10.1016/j.numecd.2009.04. 010 19800772
10. Hypertension among the Inuit from Nunavik: should we expect an increase because of obesity? Chateau-Degat ML, Dewailly E, Noël M, Valera B, Ferland A, Counil E, Poirier P, Egeland GM, Int J Circumpolar Health 2010 69 361 372 20797323
11. Diabetes mellitus in Greenland. Pedersen ML, Dan Med J 2012 59 4386 22293056
12. Prevalence of diagnosed diabetes in circumpolar indigenous populations. Young TK, Schraer CD, Shubnikoff EV, Szathmary EJ, Nikitin YP, Int J Epidemiol 1992 21 730 736 10.1093/ije/21.4.730 1521978 (Pubitemid 23364595)
13. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. Young TK, Reading J, Elias B, O'Neil JD, CMAJ 2000 163 561 566 11006768
14. Diabetes among Alaska Natives: a review. Naylor JL, Schraer CD, Mayer AM, Lanier AP, Treat CA, Murphy NJ, Int J Circumpolar Health 2003 62 363 387 14964764
15. Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project. Ebbesson SO, Schraer CD, Risica PM, Adler AI, Ebbesson L, Mayer AM, Shubnikof EV, Yeh J, Go OT, Robbins DC, Diabetes Care 1998 21 563 569 10.2337/diacare.21.4.563 9571343 (Pubitemid 28172935)
16. Diabetes in Greenland and its relationship with urbanization. Jørgensen ME, Borch-Johnsen K, Witte DR, Bjerregaard P, Diabet Med 2012 29 755 760 10.1111/j.1464-5491.2011.03527.x 22132939
17. Improvement of diabetes care in a small but geographically widely spread population in Greenland. Effects of a national diabetes care programme. Pedersen ML, Jacobsen JL, Diabet Med 2011 28 1425 1432 10.1111/j.1464-5491.2011.03337.x 21615488
18. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 Suppl 1 62 S69 20042775
19. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Bennett CM, Guo M, Dharmage SC, Diabet Med 2007 24 333 343 10.1111/j.1464-5491.2007.02106.x 17367307 (Pubitemid 46452406)
20. Alberti KGMM, Zimmet PZ, Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus Geneve: World Health Organisation, non-communicable disease surveillance 1999 1 59
21. Greenland Statistics, Population in Greenland 2012 Available from: http://www.stat.gl
22. Ministry of Health in Greenland, Report on Health Care Reform. [Danish]. 2010 [cited 2011 Nov 2] Available from: http://www.peqqik.gl. [in Danish] [Health care Reform 2010]
23. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Malkani S, Mordes JP, Am J Med 2011 124 395 401 10.1016/j.amjmed.2010.11.025 21531226
24. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, Shaw JE, Tabák AG, Vistisen D, Diabetes Care 2010 33 580 582 10.2337/dc09-1843 20009099
25. Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. John WG, UK Department of Health Advisory Committee on Diabetes, Diabet Med 2012 29 1350 1357 10.1111/j.1464-5491.2012.03762.x 22957983
26. Glycated haemoglobin-a marker and predictor of cardiovascular disease. Syed IA, Khan WA, J Pak Med Assoc 2011 61 690 695 22204248
27. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, BMJ 2000 321 405 412 10.1136/bmj.321.7258.405 10938048 (Pubitemid 30609442)
28. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC, Arch Ophthalmol 2003 121 245 251 10.1001/archopht.121.2.245 12583792 (Pubitemid 36184039)
29. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE, Australian Diabetes Obesity and Lifestyle Study Group, Diabetes Care 2008 31 1349 1354 10.2337/dc07-1707 18411241
30. International Diabetes Foundation, Diabetes atlas Fifth edition. [cited 2012 Nov 8] Available from: http://www.idf.org